You are here

  • Home
  • Archive
  • Volume 22, Issue 1
  • Weekly adalimumab significantly reduces the number of abscesses and inflammatory nodules in patients with moderate to severe hidradenitis suppurativa

Article metrics

Article menu
Download PDFPDF
Therapeutics/Prevention
Randomised controlled trial
Weekly adalimumab significantly reduces the number of abscesses and inflammatory nodules in patients with moderate to severe hidradenitis suppurativa

 

Online download statistics by month:

Online download statistics by month: January 2017 to March 2024

AbstractFullPdf
Jan 20172861651
Feb 20171341310
Mar 2017941215
Apr 20178254
May 2017451610
Jun 20172931
Jul 20176263
Aug 20176030
Sep 20177910
Oct 20176884
Nov 20176385
Dec 20176844
Jan 20184922
Feb 20184931
Mar 20185140
Apr 20182443
May 20185411
Jun 20185710
Jul 20185500
Aug 20187061
Sep 20183501
Oct 20184302
Nov 20186063
Dec 20183600
Jan 20194030
Feb 20194322
Mar 20193535
Apr 20193321
May 20193420
Jun 20193230
Jul 20193320
Aug 2019600
Sep 20191600
Oct 20193822
Nov 20192410
Dec 20192200
Jan 20202800
Feb 20202322
Mar 20202023
Apr 2020820
May 20202111
Jun 20202010
Jul 20202421
Aug 20201300
Sep 20202700
Oct 20201911
Nov 20201000
Dec 2020600
Jan 20212310
Feb 20211711
Mar 20211800
Apr 20211800
May 2021200
Jun 2021220
Jul 2021320
Aug 2021101
Sep 2021220
Oct 20212301
Nov 20214810
Dec 20212210
Jan 20221231
Feb 20223200
Mar 20222500
Apr 20222800
May 20225100
Jun 20226130
Jul 20222400
Aug 20225510
Sep 20224823
Oct 20224281
Nov 20225011
Dec 20223422
Jan 20232620
Feb 20236200
Mar 20232021
Apr 2023200
May 20232421
Jun 202311700
Jul 20234301
Aug 20231421
Sep 20234420
Oct 20232000
Nov 20233542
Dec 20232811
Jan 20242720
Feb 20243011
Mar 20242800
Total3389201158